ISRG Stock Recent News
ISRG LATEST HEADLINES
The list of companies with market caps of $1 trillion or more remains extremely short. However, there's little doubt that more companies will join this elite group over the coming decades.
The company reported a fourth-quarter earnings and sales beat, but guidance left much to be desired.
Shares of Intuitive Surgical (ISRG -3.67%) were pulling back today as a strong fourth-quarter earnings report didn't seem to be enough to justify the medical device maker's lofty valuation. Its guidance for 2025 was also slightly below estimates, which can often trigger a sell-off for growth stocks.
Intuitive Surgical Inc ISRG reported better-than-expected financial results for the fourth quarter after the market close on Thursday.
ISRG's fourth-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.
When it comes to looking for "buy-and-hold forever” stocks, there are some important things to pay attention to. The most notable is the ability of these companies to benefit from trends that are likely to remain important over long periods of time.
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q4 2024 Earnings Conference Call January 23, 2025 4:30 PM ET Company Participants Brandon Lamm - IR Gary Guthart - CEO Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Travis Steed - Bank of America Securities Rick Wise - Stifel David Roman - Goldman Sachs Patrick Wood - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Q4 2024 Intuitive Earnings Conference Call.
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Markets finished in robust fashion in the green today, ramping up in the final 20 minutes of trading.
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $1.60 per share a year ago.